MassimoS.FiandacaMDMBA, FAANS, FACS
Neurosurgery • Upper Arlington, OHExecutive Vice President, Therapeutic Strategies - CNS Gene Therapy - Asklepios BioPharmaceuticals, Inc.
Dr. Fiandaca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Asklepios BioPharmaceutical Inc - CNS Gene Therapy
2447 North Star Rd
Upper Arlington, OH 43221Phone+1 510-358-8431- Is this information wrong?
Summary
- Neurosurgeon, neuroscientist, and entrepreneur working in biotechnology company focused on vector-based gene therapy strategies and direct brain delivery technologies for human central nervous system disorders.
Current Specialties: CNS gene therapy; convection enhanced delivery (CED); neurosurgical methods and devices; translational neuroscience research; blood-based biomarkers.
Education & Training
Loyola University of Maryland, Sellinger School of Business and ManagementMBA, Business and Management, Beta Gamma Sigma, 1999 - 2001
University of Rochester Medical CenterFellowship, Neurobiology and Anatomy, 1987 - 1988
Emory University School of MedicineResidency, Neurological Surgery, 1982 - 1987- Emory University School of MedicineInternship, Surgery, 1981 - 1982
Oregon Health and Science University School of MedicineClass of 1981, MD, Alpha Omega Alpha- Oregon State UniversityBS, Zoology, 1973 - 1977
Certifications & Licensure
CA State Medical License 2016 - 2024
MD State Medical License 1991 - 2016- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Fellow (FAANS) American Association of Neurological Surgeons
- Fellow (FACS) American College of Surgeons
- Beta Gamma Sigma Loyola University of Maryland, Sellinger School, 2001
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsLong-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.Matthew T Rocco, Asad S Akhter, Debra J Ehrlich, Gretchen C Scott, Codrin Lungu, Russell R Lonser, Massimo S Fiandaca, Mark Hallett, John D Heiss, Krystof S Bankiewicz...> ;Molecular Therapy. 2022 Dec 7
- 12 citationsA retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's disease.Fabio Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, Alessio Boattini, Cristian Taccioli, Giorgia Modenini, Rond Malhas, Laura Anderlucci, Yuriy Gusev, Thomas J...> ;Geroscience. 2022 Jun 1
- 8 citationsTGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.Meena U Rajagopal, Shivani Bansal, Prabhjit Kaur, Shreyans K Jain, Tatiana Altadil, Charles P Hinzman, Yaoxiang Li, Joanna Moulton, Baldev Singh, Sunil Bansal, Siddhes...> ;Cancers. 2021 Dec 9
- Join now to see all
Journal Articles
- Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders.Fiandaca MS, Lonser RR, Elder JB, Zabek M, Bankiewicz KS, Neurol Neurochir Pol., 6/20/2020
- GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopBarker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelber..., J Parkinsons Dis, 6/9/2020
- Author Correction: Plasma microRNA markers of upper limb recovery following human stroke.Edwardson MA, Zhong X, Fiandaca MS, Federoff HJ, Cheema AK, Dromerick AW., Sci Rep., 2/9/2020
Professional Memberships
- Member
- Fellow
- Fellow
- American Society for Cell and Gene Therapy (ASGCT)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
